See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411685_2020_Vistagen_Therapeutics_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 0.6843955284084361, 'aggregate_val': 11501700, 'exp_sum': 36443400, 'exp_to_value': {'LiabilitiesCurrent': 27713000, 'LiabilitiesNoncurrent': 8730400, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0001411685, Vistagen Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 13,628,900 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 312,700 |
| 3 | remainder_Assets | 70,100 |
| 4 | LiabilitiesCurrent | 2,800,900 |
| 5 | LiabilitiesNoncurrent | 4,135,600 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,457,800 |
| 9 | ResearchAndDevelopmentExpense | 17,098,500 |
| 10 | remainder_Expenses | 2,600 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -30,700 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,011,700 |
| 1 | Liabilities | 6,936,500 |
| 2 | Expenses | 24,558,900 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 7,075,200 |
| 5 | NetIncome | -24,589,600 |
| 6 | ComprehensiveNetIncome | -24,589,600 |
| 7 | BaseVar | 22,768,900 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.875 |
| 9 | EconomicCapitalRatio | 1.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
